STOCK TITAN

WuXi AppTec Provides Updates on Q2 Share Repurchase/Acquisition Activities

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Very Positive)
Tags
buybacks

WuXi AppTec (WUXAY) has completed significant share repurchase and acquisition activities in Q2 2025. The company executed an RMB1.0 billion A-share repurchase program, buying back 15,775,377 A-shares at RMB63.39 per share (0.55% of total shares) between April 18 and June 20, 2025, which were subsequently cancelled on June 24.

Additionally, the company acquired HKD2.5 billion worth of H-shares (34,092,975 shares, 1.19% of total shares) through its 2025 H Share Award and Trust Scheme. The H-share acquisition is tied to revenue targets, with HKD1.5 billion in shares to be granted if 2025 revenue reaches RMB42.0 billion, and an additional HKD1.0 billion if revenue hits RMB43.0 billion.

Loading...
Loading translation...

Positive

  • Completed RMB1.0 billion A-share repurchase program to enhance shareholder value
  • Acquired HKD2.5 billion worth of H-shares for employee retention without diluting existing shareholders
  • H-share awards are performance-linked to ambitious revenue targets of RMB42-43 billion for 2025

Negative

  • Significant cash outlay of approximately RMB3.1 billion total for share programs
  • Share acquisitions represent relatively small percentage of total shares (combined 1.74%)

News Market Reaction

-1.76%
1 alert
-1.76% News Effect

On the day this news was published, WUXAY declined 1.76%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SHANGHAI, July 7, 2025 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, recently provided updates to investors on the status of its A-share repurchase and H-share acquisition activities in Q2 2025.

The Company repurchased and cancelled RMB1.0 billion worth of A-share to enhance shareholder value, and instructed the trustee (the "Scheme Trustee") of its 2025 H Share Award and Trust Scheme to acquire HKD2.5 billion worth of H-share for the purpose of attracting and retaining highly talented employees.

Here is a full update on both programs:  

Update on A-Share Repurchase and Cancellation:

  • On April 8, 2025, the Company's Board of Directors approved an RMB1.0 billion A-share repurchase and cancellation program. It took this action to uphold the Company's value and protect the interests of shareholders.
  • From April 18, 2025 to June 20, 2025, WuXi AppTec spent RMB1.0 billion (exclusive of transaction fees) to buy an aggregate of 15,775,377 A Shares (representing approximately 0.55% of the Company's total issued share capital as of June 23, 2025) at an average price of RMB63.39 per share.
  • On June 24, 2025, WuXi AppTec completed cancellation of all A Shares repurchased under this program.
  • For more information, please refer to the Company's relevant announcement:

Update on H-Share Acquisition:

About WuXi AppTec

WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer an integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at www.wuxiapptec.com.

 

Cision View original content:https://www.prnewswire.com/news-releases/wuxi-apptec-provides-updates-on-q2-share-repurchaseacquisition-activities-302499523.html

SOURCE WuXi AppTec

FAQ

How many shares did WuXi AppTec (WUXAY) repurchase in Q2 2025?

WuXi AppTec repurchased 15,775,377 A-shares (0.55% of total shares) at an average price of RMB63.39 per share, totaling RMB1.0 billion.

What are the revenue targets for WuXi AppTec's 2025 H Share Award scheme?

The company will grant HKD1.5 billion in H-shares if 2025 revenue reaches RMB42.0 billion, and an additional HKD1.0 billion if revenue reaches RMB43.0 billion.

How many H-shares did WuXi AppTec acquire for its employee trust scheme?

The company acquired 34,092,975 H-shares (1.19% of total shares) worth HKD2.5 billion through its 2025 H Share Award and Trust Scheme.

When did WuXi AppTec complete the cancellation of repurchased A-shares?

WuXi AppTec completed the cancellation of all repurchased A-shares on June 24, 2025.

Will WuXi AppTec's H-share acquisition dilute existing shareholders?

No, the H-share acquisition will not result in dilution to existing shareholders as these shares were purchased through on-market transactions.
Wuxi Apptec

OTC:WUXAY

WUXAY Rankings

WUXAY Latest News

WUXAY Stock Data

43.01B
2.50B
Diagnostics & Research
Healthcare
Link
China
Shanghai